Persistence of Yellow Fever vaccine-induced antibodies after cord blood stem cell transplant

Hum Vaccin Immunother. 2016 Apr 2;12(4):937-8. doi: 10.1080/21645515.2015.1112475. Epub 2015 Nov 30.

Abstract

We report the case of a cord blood haematopoietic stem cell transplant recipient who was vaccinated for Yellow Fever (YF) 7 days before initiating chemotherapy and had persistent YF antibodies more than 3 years after vaccination. Since the stem cell donor was never exposed to wild YF or to the YF vaccine, and our patient was not exposed to YF or revaccinated, this finding strongly suggests the persistence of recipient immunity. We briefly discuss potential consequences of incomplete elimination of recipient's leukocytes following existing haematopoietic cancer treatments.

Keywords: cord blood stem cell transplant; immunosuppression; vaccine; yellow fever.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Viral / blood*
  • Cord Blood Stem Cell Transplantation*
  • Humans
  • Immunosuppression Therapy
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / therapy
  • Male
  • Yellow Fever Vaccine / immunology*
  • Yellow fever virus / immunology*

Substances

  • Antibodies, Viral
  • Yellow Fever Vaccine